TLR3 and COVID-19: A recent study identified the loss-of-function mutation at the loci of TLR3 and IRF7 in severe patients with influenza and COVID-19, resulting in preventing type 1 IFN production, thus emphasizing the significance of type 1 IFN in controlling virus production (55).